Hofmann M - Search Results

1

(68)Ga-labeled peptides in tumor imaging.

Maecke HR, Hofmann M, Haberkorn U. Maecke HR, et al. Among authors: hofmann m. J Nucl Med. 2005 Jan;46 Suppl 1:172S-8S. J Nucl Med. 2005. PMID: 15653666 Free article. Review.

2

Biokinetics and imaging with the somatostatin receptor PET radioligand (68)Ga-DOTATOC: preliminary data.

Hofmann M, Maecke H, Börner R, Weckesser E, Schöffski P, Oei L, Schumacher J, Henze M, Heppeler A, Meyer J, Knapp H. Hofmann M, et al. Eur J Nucl Med. 2001 Dec;28(12):1751-7. doi: 10.1007/s002590100639. Epub 2001 Oct 31. Eur J Nucl Med. 2001. PMID: 11734911

3

PET imaging of somatostatin receptors using [68GA]DOTA-D-Phe1-Tyr3-octreotide: first results in patients with meningiomas.

Henze M, Schuhmacher J, Hipp P, Kowalski J, Becker DW, Doll J, Mäcke HR, Hofmann M, Debus J, Haberkorn U. Henze M, et al. Among authors: hofmann m. J Nucl Med. 2001 Jul;42(7):1053-6. J Nucl Med. 2001. PMID: 11438627 Free article.

4

Evaluation of positron emission tomography imaging using [68Ga]-DOTA-D Phe(1)-Tyr(3)-Octreotide in comparison to [111In]-DTPAOC SPECT. First results in patients with neuroendocrine tumors.

Kowalski J, Henze M, Schuhmacher J, Mäcke HR, Hofmann M, Haberkorn U. Kowalski J, et al. Among authors: hofmann m. Mol Imaging Biol. 2003 Jan-Feb;5(1):42-8. doi: 10.1016/s1536-1632(03)00038-6. Mol Imaging Biol. 2003. PMID: 14499161

5

68Ga-DOTANOC: a first compound for PET imaging with high affinity for somatostatin receptor subtypes 2 and 5.

Wild D, Mäcke HR, Waser B, Reubi JC, Ginj M, Rasch H, Müller-Brand J, Hofmann M. Wild D, et al. Among authors: hofmann m. Eur J Nucl Med Mol Imaging. 2005 Jun;32(6):724. doi: 10.1007/s00259-004-1697-4. Eur J Nucl Med Mol Imaging. 2005. PMID: 15551131 No abstract available.

6

68Ga-labelled DOTA-derivatised peptide ligands.

Meyer GJ, Mäcke H, Schuhmacher J, Knapp WH, Hofmann M. Meyer GJ, et al. Among authors: hofmann m. Eur J Nucl Med Mol Imaging. 2004 Aug;31(8):1097-104. doi: 10.1007/s00259-004-1486-0. Epub 2004 Mar 17. Eur J Nucl Med Mol Imaging. 2004. PMID: 15029459

7

[Follow-up of differentiated thyroid cancer patients using rhTSH--preliminary results].

Petrich T, Börner AR, Weckesser E, Soudah B, Otto D, Widjaja A, Hofmann M, Kreipe HH, Knapp WH. Petrich T, et al. Among authors: hofmann m. Nuklearmedizin. 2001 Feb;40(1):7-14. Nuklearmedizin. 2001. PMID: 11373937 German.

8

[Testing cross-calibration between positron emission tomographs and their peripheral devices].

Geworski L, Knoop BO, Hofmann M, Zander A, de Wit M, Bares R, Munz DL. Geworski L, et al. Among authors: hofmann m. Z Med Phys. 2003;13(2):109-14. doi: 10.1078/0939-3889-00150. Z Med Phys. 2003. PMID: 12868336 German.

9

Monitoring isotretinoin therapy in thyroid cancer using 18F-FDG PET.

Boerner AR, Petrich T, Weckesser E, Fricke H, Hofmann M, Otto D, Weckesser M, Langen KJ, Knapp WH. Boerner AR, et al. Among authors: hofmann m. Eur J Nucl Med Mol Imaging. 2002 Feb;29(2):231-6. doi: 10.1007/s00259-001-0702-4. Eur J Nucl Med Mol Imaging. 2002. PMID: 11926385

10

Outcome after radioiodine therapy in 107 patients with differentiated thyroid carcinoma and initial bone metastases: side-effects and influence of age.

Petrich T, Widjaja A, Musholt TJ, Hofmann M, Brunkhorst T, Ehrenheim C, Oetting G, Knapp WH. Petrich T, et al. Among authors: hofmann m. Eur J Nucl Med. 2001 Feb;28(2):203-8. doi: 10.1007/s002590000420. Eur J Nucl Med. 2001. PMID: 11303891 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,625 results

Search Page